Suppr超能文献

犬隐静脉中5-羟色胺1型受体诱导平滑肌收缩机制的研究。

Studies on the mechanism of 5-HT1 receptor-induced smooth muscle contraction in dog saphenous vein.

作者信息

Sumner M J, Feniuk W, McCormick J D, Humphrey P P

机构信息

Pharmacology Division, Glaxo Group Research Ltd., Ware, Hertfordshire.

出版信息

Br J Pharmacol. 1992 Mar;105(3):603-8. doi: 10.1111/j.1476-5381.1992.tb09026.x.

Abstract
  1. We have investigated the mechanism of smooth muscle contraction evoked by activation of 5-HT1-like receptors in dog isolated saphenous vein. 2. In the presence of the 5-HT2 receptor antagonist, ritanserin (0.1 microM), concentration-effect curves (10 nM-300 microM) for 5-hydroxytryptamine (5-HT)-induced smooth muscle contraction were biphasic. This could be attributed to a direct action on 5-HT1-like receptors at low concentrations of 5-HT (10 nM-10 microM) and an indirect (through the release of noradrenaline from sympathetic neurones) activation of postjunctional alpha-adrenoceptors at higher 5-HT concentrations. In contrast, concentration-effect curves (100 nM-100 microM) for sumatriptan-induced contractions were not biphasic, and were due solely to activation of 5-HT1-like receptors. 3. Smooth muscle contractions evoked either by low concentrations of 5-HT or by sumatriptan were abolished by removal of extracellular calcium and were markedly inhibited, but not abolished, by the calcium channel blocker, verapamil (1-30 microM). In contrast, contractions evoked by high concentrations of 5-HT were markedly less sensitive to removal of extracellular calcium or to verapamil. 4. 5-HT and sumatriptan also inhibited (to a maximum of about 50%) prostaglandin E2 (PGE2, 5 microM)-stimulated adenosine 3':5'-cyclic monophosphate (cyclic AMP) formation. This effect was mimicked by the alpha 2-adrenoceptor agonist, azepexole (B-HT933) but not by the alpha 1-adrenoceptor agonist, methoxamine.5. In contrast to mediation of smooth muscle contraction, the 5-HT1-like receptor-mediated inhibition of PGE2-stimulated cyclic AMP formation evoked by 5-HT or sumatriptan was not attenuated by removal of extracellular calcium or by verapamil (1 microM).6. A directly-acting inhibitor of adenylyl cyclase, 2',3'-dideoxyadenosine (1 mM) inhibited PGE2-stimulated cyclic AMP formation but did not produce smooth muscle contraction.7. These results suggest that contractile responses of dog isolated saphenous vein arising through activation of 5-HT1-like receptors are associated with both an influx of extracellular calcium ions (to a large extent via voltage-dependent channels) and an inhibition of adenylyl cyclase. However, although these two responses are coupled to the same receptor, they appear to be independent.
摘要
  1. 我们研究了犬离体隐静脉中5-HT1样受体激活所诱发的平滑肌收缩机制。2. 在5-HT2受体拮抗剂利坦色林(0.1微摩尔)存在的情况下,5-羟色胺(5-HT)诱导的平滑肌收缩的浓度-效应曲线(10纳摩尔至300微摩尔)呈双相性。这可归因于低浓度5-HT(10纳摩尔至10微摩尔)对5-HT1样受体的直接作用,以及较高5-HT浓度时对节后α-肾上腺素能受体的间接(通过交感神经元释放去甲肾上腺素)激活。相比之下,舒马曲坦诱导收缩的浓度-效应曲线(100纳摩尔至100微摩尔)并非双相性,且完全是由于5-HT1样受体的激活。3. 低浓度5-HT或舒马曲坦诱发的平滑肌收缩,在去除细胞外钙后被消除,并且被钙通道阻滞剂维拉帕米(1至30微摩尔)显著抑制,但未被消除。相比之下,高浓度5-HT诱发的收缩对去除细胞外钙或维拉帕米的敏感性明显较低。4. 5-HT和舒马曲坦还抑制(最大约50%)前列腺素E2(PGE2,5微摩尔)刺激的腺苷3':5'-环磷酸单酯(环磷酸腺苷)形成。α2-肾上腺素能受体激动剂阿泽必利(B-HT933)可模拟此效应,但α1-肾上腺素能受体激动剂美索明则不能。5. 与平滑肌收缩的介导作用不同,5-HT或舒马曲坦诱发的5-HT1样受体介导的对PGE2刺激的环磷酸腺苷形成的抑制作用,在去除细胞外钙或使用维拉帕米(1微摩尔)时并未减弱。6. 腺苷酸环化酶的直接作用抑制剂2',3'-二脱氧腺苷(1毫摩尔)抑制PGE2刺激的环磷酸腺苷形成,但不引起平滑肌收缩。7. 这些结果表明,犬离体隐静脉通过5-HT1样受体激活产生的收缩反应,与细胞外钙离子内流(很大程度上通过电压依赖性通道)和腺苷酸环化酶的抑制均有关。然而,尽管这两种反应与同一受体偶联,但它们似乎是独立的。

相似文献

引用本文的文献

本文引用的文献

2
Calcium messenger system: an integrated view.钙信使系统:综合观点。
Physiol Rev. 1984 Jul;64(3):938-84. doi: 10.1152/physrev.1984.64.3.938.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验